MedPath

Comparison the efficacy of Methotrexate with Immunace and Methotrexate alone on improvement of psoriasis vulgaris patients

Phase 2
Conditions
Psoriasis.
Psoriasis vulgaris
Registration Number
IRCT2014012016275N1
Lead Sponsor
Mashhad University of Medical Sciences, Vice chancellor for research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

New cases of psoriasis vulgaris (plaque) with 20% of body involvement who are new cases or don’t received systematic and or phototherapy treatment during the last 2 months; patients who complete the consent form and participate to study consciously. Exclusion criteria: Patients who want to leave the study with any reason; type one diabetes mellitus; pregnant or lactating women; patients below 20 years old; patients with familial hyperlipidemia; consumption of alcohol or alcoholic drink during study; variations in hepatic enzymes, fast blood sugar, lipid profile, cholesterol, CBC diff or ESR; any symptom which make patients to leave the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath